House Appropriations Committee Embraces Clinical Trial Issues In FY 2022 US FDA Budget Bill
Executive Summary
Report language includes several mentions of improving trial diversity and recruitment, while bill offers a 5% increase in funding.
You may also be interested in...
FDA Draft Guidance Calls For Trial Diversity Plans
Many companies have been signaling their commitment to diversity and inclusion in trials, but the new draft guidance spells out how they should address it and what the FDA wants to see.
Appropriators Continue Pressing US FDA To Conduct Surprise In-Person Inspections
Omnibus package also gives FDA expanded authority over nicotine products and creates President Biden’s Advanced Research Projects Agency for Health.
House Appropriators Continue Pressing US FDA To Conduct Surprise In-Person Inspections
The bill also would give the FDA expanded authority over nicotine products and create President Biden’s Advanced Research Projects Agency for Health.